Nuveen Fund Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
– Sell
-4,937
Closed -$320K – 128
2018
Q2
$320K Sell
4,937
-3,712
-43% -$243K 0.39% 102
2018
Q1
$620K Sell
8,649
-622
-7% -$44.8K 0.29% 107
2017
Q4
$699K Sell
9,271
-8,519
-48% -$622K 0.2% 136
2017
Q3
$1.3M Sell
17,790
-2,572
-13% -$185K 0.26% 123
2017
Q2
$1.51M Sell
20,362
-2,628
-11% -$195K 0.24% 131
2017
Q1
$1.68M Sell
22,990
-830
-3% -$58.1K 0.22% 154
2016
Q4
$1.56M Sell
23,820
-5,079
-18% -$348K 0.23% 148
2016
Q3
$2.14M Sell
28,899
-1,310
-4% -$96.8K 0.3% 112
2016
Q2
$2.21M Buy
+30,209
New +$2.15M 0.34% 95

Other funds holding CL

Nuveen Fund Advisors's CL Position: Q3 2018 in Review

Nuveen Fund Advisors sold out of Colgate-Palmolive (CL) in Q3 2018, closing a stake of 4,937 shares — an estimated $320K sold.

Nuveen Fund Advisors first reported a position in CL in Q2 2016 and held it in 9 quarters. The position peaked at $2.21M in Q2 2016. 1,393 funds tracked by Wall St. Rank hold CL as of Q3 2018.

  • Nuveen Fund Advisors reported no remaining Colgate-Palmolive position as of Q3 2018 after selling out during the quarter.
  • Nuveen Fund Advisors sold 4,937 Colgate-Palmolive shares in Q3 2018, an estimated $320K.
  • Nuveen Fund Advisors first reported a position in Colgate-Palmolive in Q2 2016 and held it in 9 quarters.
  • Nuveen Fund Advisors's Colgate-Palmolive position peaked at $2.21M in Q2 2016.
  • 1,393 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2018.

Based on Nuveen Fund Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.